Despite decades of multidrug therapy (MDT) expansion and progress toward elimination thresholds, leprosy transmission continues across multiple WHO regions, with persistent pediatric case detection and Grade-2 Disability (G2D) indicating ongoing community transmission and delayed diagnosis. These epidemiologic signals underscore the limitations of

Introduction: Androgenetic Alopecia (AGA) is the most common cause of non-scarring hair loss in adults (1). It is characterized by a gradual and progressive reduction in hair density in a typical distribution pattern (1). In men, this usually involves recession of the frontal hairline and thinning over the vertex, while the occipital scalp is relat

As we transition into 2026, Medsynapse recognizes that the most significant advancements in healthcare are born from collective expertise. Medical progress is not merely an individual pursuit; it is a testament to the shared intellect, unwavering resilience, and profound professional advocacy that defines our community. Behind every clinical breakt

The defining shift in dermatology during 2025 was the pursuit of durability. Long-acting biologics and oral small-molecule therapies improved sustained disease suppression for inflammatory skin conditions. Updated guidance reframed atopic dermatitis as a lifelong condition requiring maintenance therapy. Real-world outcomes increasingly guided thera

Introduction: Androgenetic alopecia (AGA) is the most common type of non‑scarring hair loss in men and women (1). It progresses through gradual hair follicle miniaturization and a shortened hair growth cycle (1). Men typically present with frontal hairline recession and vertex thinning (male pattern hair loss), while women show diffuse thinning ove

Introduction: Androgenetic alopecia (AGA) is a chronic, non-scarring form of hair loss that affects both men and women and is the most common type of alopecia seen in clinical practice (1). It develops due to progressive miniaturization of hair follicles and shortening of the hair growth cycle, resulting in gradual and patterned thinning (1). Early

Introduction: Impetigo is a common, highly contagious superficial bacterial skin infection affecting mainly young children (1). Although often self-limited, timely and appropriate management is important to reduce transmission, speed recovery, and prevent complications such as cellulitis, post-streptococcal glomerulonephritis, and community outbrea

Introduction: Impetigo is one of the most common superficial bacterial skin infections seen in clinical practice, particularly among children aged 2–5 years (1). The diagnosis of impetigo is primarily clinical and relies on careful evaluation of lesion morphology, distribution patterns, patient history, and epidemiological context (1). Impetigo is

In this insightful KOL (Key Opinion Leader) interview, we sit down with Dr. Raashi Mehta, a leading Dermatologist, to unpack the science and evolving practices in skin rejuvenation. With skincare trends accelerating and new treatments emerging each year, Dr. Mehta offers a grounded, evidence-based perspective that helps distinguish clinically prove